-
New DNA Blood Test May Help Guide Breast Cancer Treatment
drugs
August 09, 2019
Could the DNA from a patient's breast tumor help doctors spot whether stray cancer cells are still in her blood?
-
New Study Finds a Family Risk for Blood Cancer
drugs
August 09, 2019
If a close relative has had blood cancer, you're more likely to get it, a large new study reports.The researchers analyzed data from 16 million people in Sweden, including more than 153,000 diagnosed...
-
Breast Cancer Surgery + Another Procedure Ups Complications
drugs
August 09, 2019
Patients undergoing surgery for breast cancer, who simultaneously have either a plastic or gynecologic procedure, have greater postoperative complications, according to a study published online in The Breast Journal.
-
Bone Health Management Key in Childhood Cancer Survivors
drugs
August 07, 2019
As part of a literature review, published in the June issue of the Annals of Oncology, recommendations are presented for the management of bone health in survivors of childhood cancer.
-
Innovent and Shenogen study Tyvyt-SNG1005 combination for cancer
pharmaceutical-technology
August 07, 2019
Innovent Biologics and Shenogen Pharma Group have signed a collaboration agreement to evaluate the combination therapy of Innovent’s Tyvyt with Shenogen’s SNG1005, in patients with advanced cancer.
-
USPSTF Reaffirms Recs Against Screening for Pancreatic Cancer
drugs
August 07, 2019
The U.S. Preventive Services Task Force (USPSTF) recommends against screening for pancreatic adenocarcinoma as the potential benefits do not outweigh the potential harms.
-
Common Prostate Cancer Treatment Anti-Androgens May Increase Risk of Fatal Heart Condition
drugs
August 06, 2019
Many men with prostate cancer rely on common testosterone-blocking drugs as a part of their treatment.
-
Psychologic Distress Linked to Cervical Cancer Mortality
drugs
August 05, 2019
A clinical diagnosis of stress-related disorders or an occurrence of stressful life events around the time of cervical cancer diagnosis is associatedwith an ...
-
Finances Affect Women's Choice of Breast Cancer Treatment: Study
drugs
August 05, 2019
Cost often influences breast cancer patients' decisions about surgery, even if they have good incomes and insurance, a new study finds.
-
First Patient Dosed with the Affinity-Tailored T-Cell-adaptor in Phase I Study
americanpharmaceuticalreview
August 01, 2019
GEMoaB GmbH announced the dosing of the first patient in a Phase I open-label, dose escalation study of GEM3PSCA, an Affinity-Tailored Adapter for T-Cells (ATAC). The bispecific antibody binds to the CD3-Receptor on T-cells and prostate stem cell antigen